Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick C Fox

Showing results (301-310 of 436) with videos related to

Pageof 44
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 6, 2011
Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairmentGloria C Chiang, Philip S Insel, Duygu Tosun, et al.
Neurobiology of Aging|September 28, 2015
Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's diseaseNatalie S Ryan, Geert-Jan Biessels, Lois Kim, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 22, 2020
Amyloid β influences the relationship between cortical thickness and vascular loadThomas D Parker, David M Cash, Christopher A Lane, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 10, 2025
Early increase of the synaptic blood marker β-synuclein in asymptomatic autosomal dominant Alzheimer's diseasePatrick Oeckl, Benjamin Mayer, Randall J Bateman, et al.
Frontiers in Neurology|August 22, 2017
Eyetracking Metrics in Young Onset Alzheimer's Disease: A Window into Cognitive Visual FunctionsIvanna M Pavisic, Nicholas C Firth, Samuel Parsons, et al.
Brain : a Journal of Neurology|April 23, 2021
Plasma amyloid-β ratios in autosomal dominant Alzheimer's disease: the influence of genotypeAntoinette O'Connor, Josef Pannee, Teresa Poole, et al.
Neurobiology of Aging|June 5, 2017
ApoE influences regional white-matter axonal density loss in Alzheimer's diseaseCatherine F Slattery, Jiaying Zhang, Ross W Paterson, et al.
Molecular Psychiatry|July 16, 2020
Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort studyAntoinette O'Connor, Thomas K Karikari, Teresa Poole, et al.
The New England Journal of Medicine|January 24, 2014
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's diseaseStephen Salloway, Reisa Sperling, Nick C Fox, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's diseaseClifford R Jack, Frederik Barkhof, Matt A Bernstein, et al.
Pageof 44

Showing results (301-310 of 436) with videos related to

Sort By:
Pageof 44
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 6, 2011
Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairmentGloria C Chiang, Philip S Insel, Duygu Tosun, et al.
Neurobiology of Aging|September 28, 2015
Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's diseaseNatalie S Ryan, Geert-Jan Biessels, Lois Kim, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 22, 2020
Amyloid β influences the relationship between cortical thickness and vascular loadThomas D Parker, David M Cash, Christopher A Lane, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 10, 2025
Early increase of the synaptic blood marker β-synuclein in asymptomatic autosomal dominant Alzheimer's diseasePatrick Oeckl, Benjamin Mayer, Randall J Bateman, et al.
Frontiers in Neurology|August 22, 2017
Eyetracking Metrics in Young Onset Alzheimer's Disease: A Window into Cognitive Visual FunctionsIvanna M Pavisic, Nicholas C Firth, Samuel Parsons, et al.
Brain : a Journal of Neurology|April 23, 2021
Plasma amyloid-β ratios in autosomal dominant Alzheimer's disease: the influence of genotypeAntoinette O'Connor, Josef Pannee, Teresa Poole, et al.
Neurobiology of Aging|June 5, 2017
ApoE influences regional white-matter axonal density loss in Alzheimer's diseaseCatherine F Slattery, Jiaying Zhang, Ross W Paterson, et al.
Molecular Psychiatry|July 16, 2020
Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort studyAntoinette O'Connor, Thomas K Karikari, Teresa Poole, et al.
The New England Journal of Medicine|January 24, 2014
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's diseaseStephen Salloway, Reisa Sperling, Nick C Fox, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's diseaseClifford R Jack, Frederik Barkhof, Matt A Bernstein, et al.
Pageof 44